Abcellera Biologics Inc is a biotechnology business based in the US. Abcellera Biologics Inc shares (ABCL.US) are listed on the NASDAQ and all prices are listed in US dollars. Its last market close was $3.63 – a decrease of 6.92% over the previous day. Abcellera Biologics Inc employs 586 staff and has a trailing 12-month revenue of around $38 million.
Open your account.Provide your personal information and sign up.
Confirm your payment details.You'll need to fund your account with a bank transfer, debit card or credit card.
Search the platform for stock code:ABCL in this case.
Research stocks.The platform should provide the latest information available.
Buy your stocks.Place a market order or limit order with your preferred number of shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.
Our selection of top picks is based on the same criteria as our annual Stock Trading Platform Awards. This is updated yearly to reflect changes in the market.
"Best for" picks are those we've evaluated to be best for specific product features or categories – you can read our full methodology here. If we show a "Promoted" pick, it's been chosen from among our commercial partners and is based on factors that include special features or offers, and the commission we receive.
This isn't an exhaustive list of all the trading platforms out there. What's best for you depends on your own investing strategy, budget and financial goals.
Is it a good time to buy Abcellera Biologics Inc stock?
Only you can make the decision on the time to leap... but here's some supporting information and analysis.
Use our graph to track the performance of ABCL stocks over time.
Share price volatility
Over the last 12 months, Abcellera Biologics Inc's shares have ranged in value from as little as $3.79 up to $8.05. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Abcellera Biologics Inc's is 0.36. This would suggest that Abcellera Biologics Inc's shares are less volatile than average (for this exchange).
Historical closes compared with the last close of $3.63
1 week (2024-04-18)
-6.20%
1 month (2024-03-25)
-15.38%
3 months (2024-01-25)
-31.77%
6 months (2023-10-25)
-12.32%
1 year (2023-04-23)
-49.37%
2 years (2022-04-24)
-54.96%
3 years (2021-04-25)
-88.51%
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Frequently asked questions
We're not expecting Abcellera Biologics Inc to pay a dividend over the next 12 months. Typically it's companies that have been around for longer that pay dividends (Abcellera Biologics Inc had its IPO on 10 December 2020). However, you can browse other dividend-paying shares in our guide.
Currently 28.089% of Abcellera Biologics Inc shares are held by insiders and 43.647% by institutions.
Abcellera Biologics Inc's fiscal year ends in December.
It's as easy to sell Abcellera Biologics Inc as it is to buy! Here's how to sell Abcellera Biologics Inc stocks that you already own.
Open your investment app. If you've got one with desktop access, you can log in online
Go to your portfolio. This should be in the main menu
Find your shares. You may be able to search your portfolio
Choose how many you'd like to sell. You'll be able to review the price and see how much you'll receive
Sell your Abcellera Biologics Inc shares. Your investment platform will let you know when your shares are sold
Most dealing providers will let you use your debit card to top up your account and buy shares. The main ways are with a debit card, bank transfer or with Apple/Google Pay.
The easiest way to get hold of some Abcellera Biologics Inc shares is to sign up for a stock trading app and place a market order or basic order. This type of order tells the platform that you're interested, so it'll try to execute it as quickly as it can. It could take some time for the order to go through, especially if there's a lot of volatility in Abcellera Biologics Inc shares.
Abcellera Biologics Inc financials
Revenue TTM
$38 million
Gross profit TTM
$311.1 million
Return on assets TTM
-9.79%
Return on equity TTM
-12.27%
Profit margin
0%
Book value
$3.96
Market capitalisation
$1.1 billion
TTM: trailing 12 months
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
A failed SPAC deal pulled the plug on this vertical farming company’s plans to go public. But you can buy stock in other sustainable farming companies.
How likely would you be to recommend finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
Advertiser Disclosure
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
